Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280211038353
Abstract: Objective: To review current evidence on the use of a fixed-dose combination (FDC) of budesonide/glycopyrrolate/formoterol fumarate (BGFF) triple therapy delivered via metered dose inhaler (MDI) in patients with chronic obstructive pulmonary disease (COPD) and offer… read more here.
Keywords: bgff mdi; triple therapy; therapy; budesonide glycopyrrolate ... See more keywords